Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 58
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Semin Cancer Biol ; 80: 183-194, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-32428716

RESUMEN

The current era of cancer research has been continuously advancing upon identifying novel aspects of tumorigenesis and the principal mechanisms behind the unleashed proliferation, invasion, drug resistance and immortality of cancer cells in hopes of exploiting these findings to achieve a more effective treatment for cancer. In pursuit of this goal, the identification of the first components of an extremely important regulatory pathway in Drosophila melanogaster that largely determines cell fate during the developmental stages, ended up in the discovery of the highly sophisticated Hippo signaling cascade. Soon after, it was revealed that deregulation of the components of this pathway either via mutations or through epigenetic alterations can be observed in a vast variety of tumors and these alterations greatly contribute to the neoplastic transformation of cells, their survival, growth and resistance to therapy. As more hidden aspects of this pathway such as its widespread entanglement with other major cellular signaling pathways are continuously being uncovered, many researchers have sought over the past decade to find ways of therapeutic interventions targeting the major components of the Hippo cascade. To date, various approaches such as the use of exogenous targeting miRNAs and different molecular inhibitors have been recruited herein, among which naturally occurring compounds have shown a great promise. On such a basis, in the present work we review the current understanding of Hippo pathway and the most recent evidence on targeting its components using natural plant-derived phytochemicals.


Asunto(s)
Drosophila melanogaster , Neoplasias , Animales , Transformación Celular Neoplásica , Drosophila melanogaster/genética , Drosophila melanogaster/metabolismo , Vía de Señalización Hippo , Humanos , Neoplasias/tratamiento farmacológico , Neoplasias/genética , Neoplasias/metabolismo , Fitoquímicos/farmacología , Fitoquímicos/uso terapéutico , Proteínas Serina-Treonina Quinasas , Transducción de Señal/genética
3.
Pharmacol Res ; 152: 104626, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31904507

RESUMEN

Cardiovascular diseases comprise of non-communicable disorders that involve the heart and/or blood vessels and have become the leading cause of death worldwide with increased prevalence by age. mTOR is a serine/threonine-specific protein kinase which plays a central role in many physiological processes including cardiovascular diseases, and also integrates various proliferative signals, nutrient and energy abundance and stressful situations. mTOR also acts as central regulator during chronic stress, mitochondrial dysfunction and deregulated autophagy which are associated with senescence. Under oxidative stress, mTOR has been reported to exert protective effects regulating apoptosis and autophagy processes and favoring tissue repair. On the other hand, inhibition of mTOR has been suggested to have beneficial effects against atherosclerosis, cardiac hypertrophy and heart failure, and also in extending the lifespan. In this aspect, the use of drugs or natural compounds, which can target mTOR is an interesting approach in order to reduce the number of deaths caused by cardiovascular disease. In the present review, we intend to shed light on the possible effects and molecular mechanism of natural agents like polyphenols via regulating mTOR.


Asunto(s)
Enfermedades Cardiovasculares/tratamiento farmacológico , Enfermedades Cardiovasculares/metabolismo , Polifenoles/farmacología , Polifenoles/uso terapéutico , Serina-Treonina Quinasas TOR/metabolismo , Animales , Humanos , Transducción de Señal/efectos de los fármacos , Serina-Treonina Quinasas TOR/antagonistas & inhibidores
4.
Rev Med Virol ; 29(4): e2048, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-31265195

RESUMEN

Seropositivity for HSV reaches more than 70% within the world population, and yet no approved vaccine exists. While HSV1 is responsible for keratitis, encephalitis, and labialis, HSV2 carriers have a high susceptibility to other STD infections, such as HIV. Induction of antiviral innate immune responses upon infection depends on a family of pattern recognition receptors called Toll-like receptors (TLR). TLRs bridge innate and adaptive immunity by sensing virus infection and activating antiviral immune responses. HSV adopts smart tricks to evade innate immunity and can also manipulate TLR signaling to evade the immune system or even confer destructive effects in favor of virus replication. Here, we review mechanisms by which HSV can trick TLR signaling to impair innate immunity. Then, we analyze the role of HSV-mediated molecular cues, in particular, NF-κB signaling, in promoting protective versus destructive effects of TLRs. Finally, TLR-based therapeutic opportunities with the goal of preventing or treating HSV infection will be discussed.


Asunto(s)
Terapia Biológica/métodos , Herpes Simple/inmunología , Herpes Simple/terapia , Inmunidad Innata , Simplexvirus/inmunología , Receptores Toll-Like/metabolismo , Interacciones Microbiota-Huesped , Humanos , Evasión Inmune , Simplexvirus/patogenicidad
5.
Food Chem Toxicol ; 129: 434-443, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31022478

RESUMEN

Mood disorders occur in 30% of stroke patients, and of these post-stroke depression (PSD) is the most significant. This study aimed to evaluate the antidepressive-like effects and in vivo antioxidant activity of a chemically characterized maqui berry (Aristotelia chilensis (Molina) Stuntz) extract obtained from an optimized extraction method, on a murine PSD model. The extraction process was optimized to maximize anthocyanin content, and the phytochemical profile of the extract was evaluated using a multi-methodological approach including a liquid chromatographic method coupled with mass spectrometry and nuclear magnetic resonance spectroscopy. The antidepressive-like activity was investigated through despair swimming and tail suspension tests. The in vivo antioxidant activity was evaluated in mouse brain tissue by measuring the activity of antioxidant enzymes and lipid peroxidation products. A number of compounds have been first identified in maqui berry here, including malvidin-glucoside, GABA, choline and trigonelline. Moreover, the results showed that the antidepressive-like activity exerted by the extract, which was found to restore normal mouse behavior in both despair swimming and tail suspension tests, could be linked to its antioxidant activity, leading to the conclusion that maqui berries might be useful for supporting pharmacological therapy of PSD by modulating oxidative stress.


Asunto(s)
Antidepresivos/farmacología , Depresión/tratamiento farmacológico , Elaeocarpaceae/química , Extractos Vegetales/farmacología , Accidente Cerebrovascular/tratamiento farmacológico , Animales , Antidepresivos/uso terapéutico , Depresión/etiología , Modelos Animales de Enfermedad , Ratones , Extractos Vegetales/uso terapéutico , Accidente Cerebrovascular/complicaciones
6.
Daru ; 27(1): 407-421, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30927208

RESUMEN

BACKGROUND: Over the last two decades there has been a substantial increase of the number of studies on the species of genus Sideritis. Species of section Empedoclia, occurring in the Eastern Mediterranean region and in part of Western Asia possess some remarkable characteristics and are known as valuable medicinal plants used by local people in the traditional medicine and for herbal tea. The objective of the review is to make a survey on the recent studies on the ethnopharmacology and biological activity of the species in Southeastern Europe and in Turkey, which is the center of distribution and their main occurrence. MAIN BODY: The review focuses on the ethnopharmacology and biological activities of the species of interest. The survey revealed that a total of 47 species belonging to section Empedoclia have been studied either in ethnopharmacological aspect, or in relation to their biological activities, or both. Most species have been used traditionally by the local people as herbal tea or for treatment of various health problems, most frequently flu, cold and respiratory diseases. Sideritis species demonstrate numerous biological activities and are promising for use in the therapy of many diseases and health disorders. Antioxidant activity was found in 40 species, antimicrobial and antibacterial activity - in 27 species, anti-inflammatory - in 14 species, antifungal - in 8 species, cytotoxic - in 7 species. There were also some other, more specific biological activities, found in a few species, but considered promising for further studies and application. SHORT CONCLUSION: The species of genus Sideritis, section Empedoclia have been used by local people as herbal tea and in traditional medicine since long time ago. People are taking advantage of the high species diversity and are aware of their useful properties. Much more information is available on the biological activities of the target species than on their traditional uses. Most species demonstrate various biological activities and are of substantial interest for further studies on their pharmacological properties and their potential for pharmacy and medicine. Graphical abstract Schematic illustration of traditional uses and biological activities of some Sideritis species. Arrows with different colors represent biological activities of different species. The species and their corresponding color can be seen at the right part of the figure. The colors correspond also to the squares placed in the different parts of human body.


Asunto(s)
Extractos Vegetales/farmacología , Sideritis/clasificación , Antiinfecciosos/química , Antiinfecciosos/farmacología , Antiinflamatorios/química , Antiinflamatorios/farmacología , Antioxidantes/química , Antioxidantes/farmacología , Citotoxinas/química , Citotoxinas/farmacología , Etnofarmacología , Europa (Continente) , Humanos , Extractos Vegetales/química , Plantas Medicinales/química , Plantas Medicinales/clasificación , Sideritis/química , Tés de Hierbas , Turquía
7.
Crit Rev Food Sci Nutr ; 59(sup1): S4-S16, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-29902071

RESUMEN

N-acetyl-5-methoxy-tryptamine (melatonin) is a natural substance produced both by plants, as a secondary metabolite, and animals, by the pineal gland and other tissues. In humans, melatonin participates in numerous functions including the regulation of mood, sleep, reproduction, promotion of immunomodulation, antioxidant defense and as an anti-inflammatory agent. The anti-inflammatory activity of melatonin could yield beneficial effects on intake, particularly against the chronic inflammation which underlies many chronic diseases. This review aims to provide an assessment of the literature data on the anti-inflammatory activity of melatonin, with a particular focus on the mechanisms responsible for this behavior. We can conclude that many in vitro studies and in vivo studies in experimental animal model systems show that melatonin exerts anti-inflammatory activity in a number of chronic diseases which affect different organs in different circumstances. Clinical trials, however, often fail to reach positive results and are thus far inconclusive. Thus, in the future, long-term well-designed investigations on melatonin-rich foods or melatonin food supplements could provide valuable information towards public health recommendations on melatonin, taking into account both the nature of the compound and the optimal dose, for protection from long-term inflammation linked to chronic diseases.


Asunto(s)
Antiinflamatorios/farmacología , Melatonina/farmacología , Animales , Sistema Cardiovascular/efectos de los fármacos , Enfermedad Crónica , Ensayos Clínicos como Asunto , Bases de Datos Factuales , Modelos Animales de Enfermedad , Análisis de los Alimentos , Tracto Gastrointestinal/efectos de los fármacos , Humanos , Inflamación/tratamiento farmacológico , Melatonina/análisis , Músculo Esquelético/efectos de los fármacos , Sistema Nervioso/efectos de los fármacos
8.
Pharmacol Res ; 141: 73-84, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30550953

RESUMEN

JAK/STAT transduction pathway is a highly conserved pathway implicated in regulating cellular proliferation, differentiation, survival and apoptosis. Dysregulation of this pathway is involved in the onset of autoimmune, haematological, oncological, metabolic and neurological diseases. Over the last few years, the research of anti-neuroinflammatory agents has gained considerable attention. The ability to diminish the STAT-induced transcription of inflammatory genes is documented for both natural compounds (such as polyphenols) and chemical drugs. Among polyphenols, quercetin and curcumin directly inhibit STAT, while Berberis vulgaris L. and Sophora alopecuroides L extracts act indirectly. Also, the Food and Drug Administration has approved several JAK/STAT inhibitors (direct or indirect) for treating inflammatory diseases, indicating STAT can be considered as a therapeutic target for neuroinflammatory pathologies. Considering the encouraging data obtained so far, clinical trials are warranted to demonstrate the effectiveness and potential use in the clinical practice of STAT inhibitors to treat inflammation-associated neurodegenerative pathologies.


Asunto(s)
Antiinflamatorios/uso terapéutico , Inflamación/tratamiento farmacológico , Enfermedades del Sistema Nervioso/tratamiento farmacológico , Factores de Transcripción STAT/antagonistas & inhibidores , Animales , Antiinflamatorios/farmacología , Humanos , Inflamación/metabolismo , Enfermedades del Sistema Nervioso/metabolismo , Polifenoles/farmacología , Polifenoles/uso terapéutico , Factores de Transcripción STAT/química , Factores de Transcripción STAT/metabolismo
9.
Pharmacol Res ; 135: 37-48, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-29990625

RESUMEN

Neurodegenerative diseases (NDs) such as Parkinson's (PD), Alzheimer's (AD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) cause significant world-wide morbidity and mortality. To date, there is no drug of cure for these, mostly age-related diseases, although approaches in delaying the pathology and/or giving patients some symptomatic relief have been adopted for the last few decades. Various studies in recent years have shown the beneficial effects of omega-3 poly unsaturated fatty acids (PUFAs) through diverse mechanisms including anti-inflammatory effects. This review now assesses the potential of this class of compounds in NDs therapy through specific action against the mammalian target of rapamycin (mTOR) signaling pathway. The role of mTOR in neurodegenerative diseases and targeted therapies by PUFAs are discussed.


Asunto(s)
Ácidos Grasos Omega-3/farmacología , Enfermedades Neurodegenerativas/metabolismo , Serina-Treonina Quinasas TOR/metabolismo , Animales , Ácidos Grasos Omega-3/uso terapéutico , Humanos , Enfermedades Neurodegenerativas/tratamiento farmacológico , Transducción de Señal/efectos de los fármacos
10.
Biomed Pharmacother ; 99: 290-298, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29353203

RESUMEN

Hypericum androsaemum L., commonly known as 'tutsan' or 'shrubby St. John's Wort', is a member of the Hypericum genus found growing spontaneously in the Mediterranean area and is cultivated extensively as an ornamental plant due to the showy color variation in its fresh berry-like capsules, which turn from red to shiny black as they ripen. Tutsan has also been used in Portuguese and Spanish folk medicine to treat depression. In this study, we assessed the beneficial role of the water extract of H. androsaemum red berries (WE) in an experimental animal model of post-stroke depression. WE was obtained by decoction of H. androsaemum red berries, and its content of ten bioactive compounds was determined through HPLC-DAD analysis. Behavioral tests were carried out using a mouse model of post stroke depression to examine the antidepressive-like activity of WE at two doses (15 and 30 mg/kg bw). In addition, the in vivo antioxidant activity in the mouse brain was evaluated by measuring CAT, GSH, and SOD activity and TBARS levels. WE contained significant amounts of shikimic acid (110.0 g/kg), chlorogenic acid (56.9 g/kg), catechin (5.8 g/kg) and hyperoside (2.7 g/kg). Overall, the highest dosage of WE was found to significantly reduce the symptoms of depression, restoring normal behaviour and reducing levels of oxidative stress by increasing endogenous antioxidant defenses. The protective effects of WE in post-stroke depression in a mouse model were demonstrated in vivo for the first time, and correlated with the antioxidant capacity of its bioactive constituents.


Asunto(s)
Antidepresivos/uso terapéutico , Antioxidantes/uso terapéutico , Depresión/tratamiento farmacológico , Frutas/química , Hypericum/química , Extractos Vegetales/uso terapéutico , Accidente Cerebrovascular/psicología , Agua/química , Animales , Antidepresivos/farmacología , Antioxidantes/farmacología , Cromatografía Líquida de Alta Presión , Depresión/etiología , Modelos Animales de Enfermedad , Suspensión Trasera , Masculino , Ratones Endogámicos BALB C , Extractos Vegetales/farmacología , Accidente Cerebrovascular/complicaciones , Natación
11.
Pharmacol Res ; 128: 366-375, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28951297

RESUMEN

Activator protein 1 (AP-1) is a key transcription factor in the control of several cellular processes responsible for cell survival proliferation and differentiation. Dysfunctional AP-1 expression and activity are involved in several severe diseases, especially inflammatory disorders and cancer. Therefore, targeting AP-1 has recently emerged as an attractive therapeutic strategy for cancer prevention and therapy. This review summarizes our current understanding of AP-1 biology and function as well as explores and discusses several natural bioactive compounds modulating AP-1-associated signaling pathways for cancer prevention and intervention. Current limitations, challenges, and future directions of research are also critically discussed.


Asunto(s)
Neoplasias/metabolismo , Factor de Transcripción AP-1/metabolismo , Animales , Apoptosis/efectos de los fármacos , Productos Biológicos/farmacología , Humanos , Neoplasias/tratamiento farmacológico , Neoplasias/prevención & control , Fitoquímicos/farmacología , Transducción de Señal/efectos de los fármacos , Ligando Inductor de Apoptosis Relacionado con TNF/metabolismo
12.
Materials (Basel) ; 10(8)2017 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-28809799

RESUMEN

p-Cymene [1-methyl-4-(1-methylethyl)-benzene] is a monoterpene found in over 100 plant species used for medicine and food purposes. It shows a range of biological activity including antioxidant, anti-inflammatory, antinociceptive, anxiolytic, anticancer and antimicrobial effects. This last property has been widely investigated due to the urgent need for new substances with antimicrobial properties, to be used to treat communicable diseases whose diffusion in developed countries has been facilitated by globalization and the evolution of antimicrobial resistance. This review summarizes available scientific data, as reported by the most recent studies describing the antimicrobial activity of p-cymene either alone, or as the main component of plant extracts, as well as addressing the mechanisms of action of cymenes as antimicrobial agents. While p-cymene is one of the major constituents of extracts and essential oils used in traditional medicines as antimicrobial agents, but considering the limited data on its in vivo efficacy and safety, further studies are required to reach a definitive recommendation on the use and beneficial effects of p-cymene in human healthcare and in biomedical applications as a promising candidate to functionalize biomaterials and nanomaterials.

13.
Biofactors ; 43(6): 760-769, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28817221

RESUMEN

The incidence of neurological disorders is growing in developed countries together with increased lifespan. Nowadays, there are still no effective treatments for neurodegenerative pathologies, which make necessary to search for new therapeutic agents. Natural products, most of them used in traditional medicine, are considered promising alternatives for the treatment of neurodegenerative diseases. Honokiol is a natural bioactive phenylpropanoid compound, belonging to the class of neolignan, found in notable amounts in the bark of Magnolia tree, and has been reported to exert diverse pharmacological properties including neuroprotective activities. Honokiol can permeate the blood brain barrier and the blood-cerebrospinal fluid to increase its bioavailability in neurological tissues. Diverse studies have provided evidence on the neuroprotective effect of honokiol in the central nervous system, due to its potent antioxidant activity, and amelioration of the excitotoxicity mainly related to the blockade of glutamate receptors and reduction in neuroinflammation. In addition, recent studies suggest that honokiol can attenuate neurotoxicity exerted by abnormally aggregated Aß in Alzheimer's disease. The present work summarizes what is currently known concerning the neuroprotective effects of honokiol and its potential molecular mechanisms of action, which make it considered as a promising agent in the treatment and management of neurodegenerative diseases. © 2017 BioFactors, 43(6):760-769, 2017.


Asunto(s)
Antioxidantes/farmacología , Compuestos de Bifenilo/farmacología , Sistema Nervioso Central/efectos de los fármacos , Lignanos/farmacología , Magnolia/química , Enfermedades Neurodegenerativas/tratamiento farmacológico , Fármacos Neuroprotectores/farmacología , Péptidos beta-Amiloides/antagonistas & inhibidores , Péptidos beta-Amiloides/genética , Péptidos beta-Amiloides/inmunología , Antioxidantes/aislamiento & purificación , Antioxidantes/farmacocinética , Productos Biológicos/química , Transporte Biológico , Compuestos de Bifenilo/aislamiento & purificación , Compuestos de Bifenilo/farmacocinética , Barrera Hematoencefálica/inmunología , Barrera Hematoencefálica/metabolismo , Sistema Nervioso Central/inmunología , Sistema Nervioso Central/patología , Citocinas/antagonistas & inhibidores , Citocinas/genética , Citocinas/inmunología , Regulación de la Expresión Génica , Humanos , Lignanos/aislamiento & purificación , Lignanos/farmacocinética , Factores de Crecimiento Nervioso/antagonistas & inhibidores , Factores de Crecimiento Nervioso/genética , Factores de Crecimiento Nervioso/inmunología , Enfermedades Neurodegenerativas/genética , Enfermedades Neurodegenerativas/inmunología , Enfermedades Neurodegenerativas/patología , Fármacos Neuroprotectores/aislamiento & purificación , Fármacos Neuroprotectores/farmacocinética , Corteza de la Planta/química , Receptores de Glutamato/genética , Receptores de Glutamato/inmunología
14.
Nutrients ; 9(5)2017 Apr 29.
Artículo en Inglés | MEDLINE | ID: mdl-28468264

RESUMEN

Green GABA (GGABA) and Oolong GABA (OGABA) teas are relatively new varieties of tea, whose chemical composition and functional properties are largely under-studied, despite their promising health capacities. Post stroke depression (PSD) is a complication of stroke with high clinical relevance, yielding increasing mortality and morbidity rates, and a lower response to common therapies and rehabilitation. METHODS: Two chemically characterized commercial samples of GGABA and OGABA were investigated for effects on mood following oral administration using a mouse model of PSD, through common validated tests including the Despair Swimming Test and Tail Suspension Test. Moreover, the antioxidant activity of GGABA and OGABA was evaluated by determining the levels of lipid peroxidation products and the activity of antioxidant enzymes in the mouse brain in vivo. RESULTS: GGABA and OGABA attenuated depressed mood by influencing behavioral parameters linked to depression. GGABA was more active than OGABA in this study, and this effect may be likely due to a higher content of polyphenolic substances and amino acids in GGABA compared to OGABA. GGABA also exerted a greater antioxidant activity. CONCLUSIONS: Our data suggests that GABA tea is a promising candidate that can be used as an adjuvant in the management of PSD.


Asunto(s)
Afecto/efectos de los fármacos , Depresión/tratamiento farmacológico , Extractos Vegetales/farmacología , Té/química , Ácido gamma-Aminobutírico/farmacología , Animales , Modelos Animales de Enfermedad , Glutamatos/farmacología , Ácido Glutámico/farmacología , Glutamina/farmacología , Peroxidación de Lípido/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , Polifenoles/farmacología , Reproducibilidad de los Resultados , Accidente Cerebrovascular/tratamiento farmacológico , Accidente Cerebrovascular/psicología
15.
CNS Neurol Disord Drug Targets ; 16(4): 387-397, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28474543

RESUMEN

Neurodegenerative diseases, namely Alzheimer's disease and Parkinson's disease represent a deleterious impact worldwide. Despite extensive preclinical and clinical research in neurodegenerative disorders, therapeutic strategies aimed at the prevention and chronic treatment of neurodegenerative conditions have not been successfully translated to the clinic. Therefore, the identification of novel pharmacological intervention derived from natural products is warranted. Nobiletin and tangeretin are important citrus flavonoids derived from the peel and other parts of Citrus L. genus, and have been shown to exhibit neuroprotective effects in several in vitro and in vivo studies. Apart from there antioxidant and anti-inflammatory effects, nobiletin and tangeretin have been shown to attenuate cholinergic deficits, reduce the abnormal accumulation of neurotoxic amyloid-beta peptides, reverse N-methyl- D-aspartate (NMDA) receptor hypofunction, ameliorate ischemic injury, inhibit hyperphosphorylation of tau protein, enhance neprilysin levels, modulate several signaling cascades, and protect against 1-methyl-4-phenylpyridinium (MPP(+)) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity. Taken together, these naturally occurring phytochemicals may represent beneficial drug candidates for the treatment and prevention of Alzheimer's and Parkinson's disease.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Flavonas/farmacología , Flavonoides/farmacología , Fármacos Neuroprotectores/farmacología , Enfermedad de Parkinson/tratamiento farmacológico , Animales , Citrus/química , Flavonas/química , Flavonas/uso terapéutico , Flavonoides/química , Flavonoides/uso terapéutico , Humanos , Fármacos Neuroprotectores/química , Fármacos Neuroprotectores/uso terapéutico , Fitoterapia
16.
Crit Rev Microbiol ; 43(6): 668-689, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28346030

RESUMEN

Eugenol is a hydroxyphenyl propene, naturally occurring in the essential oils of several plants belonging to the Lamiaceae, Lauraceae, Myrtaceae, and Myristicaceae families. It is one of the major constituents of clove (Syzygium aromaticum (L.) Merr. & L.M. Perry, Myrtaceae) oil and is largely used in both foods and cosmetics as a flavoring agent. A large body of recent scientific evidence supports claims from traditional medicine that eugenol exerts beneficial effects on human health. These effects are mainly associated with antioxidant and anti-inflammatory activities. Eugenol has also shown excellent antimicrobial activity in studies, being active against fungi and a wide range of gram-negative and gram-positive bacteria. The aim of this review is to analyze scientific data from the main published studies describing the antibacterial and antifungal activities of eugenol targeting different kind of microorganisms, such as those responsible for human infectious diseases, diseases of the oral cavity, and food-borne pathogens. This article also reports the effects of eugenol on multi-drug resistant microorganisms. On the basis of this collected data, eugenol represents a very interesting bioactive compound with broad spectrum antimicrobial activity against both planktonic and sessile cells belonging to food-decaying microorganisms and human pathogens.


Asunto(s)
Antibacterianos/farmacología , Antifúngicos/farmacología , Bacterias/efectos de los fármacos , Enfermedades Transmisibles/tratamiento farmacológico , Eugenol/farmacología , Hongos/efectos de los fármacos , Aceites Volátiles/farmacología , Antiinflamatorios/farmacología , Antioxidantes/farmacología , Membrana Celular/efectos de los fármacos , Enfermedades Transmisibles/microbiología , Enfermedades Transmitidas por los Alimentos/tratamiento farmacológico , Enfermedades Transmitidas por los Alimentos/microbiología , Humanos , Pruebas de Sensibilidad Microbiana , Syzygium/química
17.
Int J Mol Sci ; 18(3)2017 Mar 16.
Artículo en Inglés | MEDLINE | ID: mdl-28300756

RESUMEN

Nowadays, much attention has been paid to diet and dietary supplements as a cost-effective therapeutic strategy for prevention and treatment of a myriad of chronic and degenerative diseases. Rapidly accumulating scientific evidence achieved through high-throughput technologies has greatly expanded the understanding about the multifaceted nature of cancer. Increasingly, it is being realized that deregulation of spatio-temporally controlled intracellular signaling cascades plays a contributory role in the onset and progression of cancer. Therefore, targeting regulators of oncogenic signaling cascades is essential to prevent and treat cancer. A plethora of preclinical and epidemiological evidences showed promising role of phytochemicals against several types of cancer. Oleanolic acid, a common pentacyclic triterpenoid, is mainly found in olive oil, as well as several plant species. It is a potent inhibitor of cellular inflammatory process and a well-known inducer of phase 2 xenobiotic biotransformation enzymes. Main molecular mechanisms underlying anticancer effects of oleanolic acid are mediated by caspases, 5' adenosine monophosphate-activated protein kinase, extracellular signal-regulated kinase 1/2, matrix metalloproteinases, pro-apoptotic Bax and bid, phosphatidylinositide 3-kinase/Akt1/mechanistic target of rapamycin, reactive oxygen species/apoptosis signal-regulating kinase 1/p38 mitogen-activated protein kinase, nuclear factor-κB, cluster of differentiation 1, CKD4, s6k, signal transducer and activator of transcription 3, as well as aforementioned signaling pathways . In this work, we critically review the scientific literature on the molecular targets of oleanolic acid implicated in the prevention and treatment of several types of cancer. We also discuss chemical aspects, natural sources, bioavailability, and safety of this bioactive phytochemical.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias/prevención & control , Ácido Oleanólico/farmacología , Transducción de Señal/efectos de los fármacos , Animales , Antineoplásicos/administración & dosificación , Antineoplásicos/química , Antineoplásicos/uso terapéutico , Dieta Saludable , Humanos , Neoplasias/tratamiento farmacológico , Neoplasias/metabolismo , Ácido Oleanólico/administración & dosificación , Ácido Oleanólico/química , Ácido Oleanólico/uso terapéutico
18.
Semin Cancer Biol ; 46: 146-157, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28185862

RESUMEN

In the recent years, polyphenols have gained significant attention in scientific community owing to their potential anticancer effects against a wide range of human malignancies. Epidemiological, clinical and preclinical studies have supported that daily intake of polyphenol-rich dietary fruits have a strong co-relationship in the prevention of different types of cancer. In addition to direct antioxidant mechanisms, they also regulate several therapeutically important oncogenic signaling and transcription factors. However, after the discovery of microRNA (miRNA), numerous studies have identified that polyphenols, including epigallocatechin-3-gallate, genistein, resveratrol and curcumin exert their anticancer effects by regulating different miRNAs which are implicated in all the stages of cancer. MiRNAs are short, non-coding endogenous RNA, which silence the gene functions by targeting messenger RNA (mRNA) through degradation or translation repression. However, cancer associated miRNAs has emerged only in recent years to support its applications in cancer therapy. Preclinical experiments have suggested that deregulation of single miRNA is sufficient for neoplastic transformation of cells. Indeed, the widespread deregulation of several miRNA profiles of tumor and healthy tissue samples revealed the involvement of many types of miRNA in the development of numerous cancers. Hence, targeting the miRNAs using polyphenols will be a novel and promising strategy in anticancer chemotherapy. Herein, we have critically reviewed the potential applications of polyphenols on various human miRNAs, especially which are involved in oncogenic and tumor suppressor pathways.


Asunto(s)
MicroARNs/genética , Neoplasias/dietoterapia , Polifenoles/uso terapéutico , Catequina/análogos & derivados , Catequina/uso terapéutico , Curcumina/uso terapéutico , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Genisteína/uso terapéutico , Humanos , MicroARNs/efectos de los fármacos , Neoplasias/genética , Neoplasias/patología , Resveratrol , Transducción de Señal/efectos de los fármacos , Estilbenos/uso terapéutico
19.
Ageing Res Rev ; 36: 11-19, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28235660

RESUMEN

A wide array of cell signaling mediators and their interactions play vital roles in neuroinflammation associated with ischemia, brain trauma, developmental disorders and age-related neurodegeneration. Along with neurons, microglia and astrocytes are also affected by the inflammatory cascade by releasing pro-inflammatory cytokines, chemokines and reactive oxygen species. The release of pro-inflammatory mediators in response to neural dysfunction may be helpful, neutral or even deleterious to normal cellular survival. Moreover, the important role of NF-κB factors in the central nervous system (CNS) through toll-like receptor (TLR) activation has been well established. This review demonstrates recent findings regarding therapeutic aspects of polyphenolic compounds for the treatment of neuroinflammation, with the aim of regulating TLR4. Polyphenols including flavonoids, phenolic acids, phenolic alcohols, stilbenes and lignans, can target TLR4 signaling pathways in multiple ways. Toll interacting protein expression could be modulated by epigallocatechin-3-gallate. Resveratrol may also exert neuroprotective effects via the TLR4/NF-κB/STAT signaling cascade. Its role in activation of cascade via interfering with TLR4 oligomerization upon receptor stimulation has also been reported. Curcumin, another polyphenol, can suppress overexpression of inflammatory mediators via inhibiting the TLR4-MAPK/NF-κB pathway. It can also reduce neuronal apoptosis via a mechanism concerning the TLR4/MyD88/NF-κB signaling pathway in microglia/macrophages. Despite a symphony of in vivo and in vitro studies, many molecular and pharmacological aspects of neuroinflammation remain unclear. It is proposed that natural compounds targeting TLR4 may serve as important pharmacophores for the development of potent drugs for the treatment of neurological disorders.


Asunto(s)
Sistemas de Liberación de Medicamentos/tendencias , Mediadores de Inflamación/metabolismo , Polifenoles/administración & dosificación , Polifenoles/metabolismo , Receptor Toll-Like 4/metabolismo , Animales , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Sistemas de Liberación de Medicamentos/métodos , Humanos , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Mediadores de Inflamación/antagonistas & inhibidores , Microglía/efectos de los fármacos , Microglía/metabolismo , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología
20.
Microbiol Res ; 196: 44-68, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28164790

RESUMEN

In recent years, many studies have shown that phytochemicals exert their antibacterial activity through different mechanisms of action, such as damage to the bacterial membrane and suppression of virulence factors, including inhibition of the activity of enzymes and toxins, and bacterial biofilm formation. In this review, we summarise data from the available literature regarding the antibacterial effects of the main phytochemicals belonging to different chemical classes, alkaloids, sulfur-containing phytochemicals, terpenoids, and polyphenols. Some phytochemicals, besides having direct antimicrobial activity, showed an in vitro synergistic effect when tested in combination with conventional antibiotics, modifying antibiotic resistance. Review of the literature showed that phytochemicals represent a possible source of effective, cheap and safe antimicrobial agents, though much work must still be carried out, especially in in vivo conditions to ensure the selection of effective antimicrobial substances with low side and adverse effects.


Asunto(s)
Antibacterianos/farmacología , Fitoquímicos/farmacología , Extractos Vegetales/farmacología , Alcaloides/química , Alcaloides/clasificación , Alcaloides/farmacología , Antibacterianos/química , Antibacterianos/economía , Infecciones Bacterianas/tratamiento farmacológico , Carotenoides/química , Carotenoides/farmacología , Farmacorresistencia Microbiana , Humanos , Pruebas de Sensibilidad Microbiana , Fitoquímicos/química , Fitoquímicos/economía , Extractos Vegetales/química , Extractos Vegetales/economía , Polifenoles/química , Polifenoles/clasificación , Polifenoles/farmacología , Terpenos/química , Terpenos/clasificación , Terpenos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA